Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Mitchell

Showing results (151-160 of 175) with videos related to

Pageof 18
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1990
Active-specific immunotherapy for melanomaM S Mitchell, W Harel, R A Kempf, et al.
Cancer|March 1, 1972
Combination sequential chemotherapy in advanced reticulum cell sarcomaM Levitt, J C Marsh, R C DeConti, et al.
Research Communications in Chemical Pathology and Pharmacology|June 1, 1980
Metabolism of methotrexate in man after high and conventional dosesK K Chan, M S Nayar, J L Cohen, et al.
The American Journal of Gastroenterology|April 20, 2004
Changing patterns of colorectal cancerJonathan S White, Kevin McCallion, Keith R Gardiner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1994
Sustained regression of a primary choroidal melanoma under the influence of a therapeutic melanoma vaccineM S Mitchell, P E Liggett, R L Green, et al.
Cancer Research|January 1, 1988
Biotechnology products in cancer therapy: a colloquiumE C Borden, E C Bradley, C H Evans, et al.
Journal of Biological Response Modifiers|January 1, 1983
Immunological effects of recombinant interferon-alpha 2 in cancer patientsJ C Hengst, R A Kempf, J Kan-Mitchell, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Lymphocytes cytotoxic to uveal and skin melanoma cells from peripheral blood of ocular melanoma patientsJ Kan-Mitchell, P E Liggett, W Harel, et al.
Cancer Research|January 1, 1985
Correlation between cytotoxic and suppressor activities of human pulmonary alveolar macrophagesJ C Hengst, J Kan-Mitchell, R A Kempf, et al.
Cancer|July 1, 1978
Combination chemotherapy for advanced breast cancer: two regimens containing adriamycinG T Kennealey, B Boston, M S Mitchell, et al.
Pageof 18

Showing results (151-160 of 175) with videos related to

Sort By:
Pageof 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1990
Active-specific immunotherapy for melanomaM S Mitchell, W Harel, R A Kempf, et al.
Cancer|March 1, 1972
Combination sequential chemotherapy in advanced reticulum cell sarcomaM Levitt, J C Marsh, R C DeConti, et al.
Research Communications in Chemical Pathology and Pharmacology|June 1, 1980
Metabolism of methotrexate in man after high and conventional dosesK K Chan, M S Nayar, J L Cohen, et al.
The American Journal of Gastroenterology|April 20, 2004
Changing patterns of colorectal cancerJonathan S White, Kevin McCallion, Keith R Gardiner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1994
Sustained regression of a primary choroidal melanoma under the influence of a therapeutic melanoma vaccineM S Mitchell, P E Liggett, R L Green, et al.
Cancer Research|January 1, 1988
Biotechnology products in cancer therapy: a colloquiumE C Borden, E C Bradley, C H Evans, et al.
Journal of Biological Response Modifiers|January 1, 1983
Immunological effects of recombinant interferon-alpha 2 in cancer patientsJ C Hengst, R A Kempf, J Kan-Mitchell, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Lymphocytes cytotoxic to uveal and skin melanoma cells from peripheral blood of ocular melanoma patientsJ Kan-Mitchell, P E Liggett, W Harel, et al.
Cancer Research|January 1, 1985
Correlation between cytotoxic and suppressor activities of human pulmonary alveolar macrophagesJ C Hengst, J Kan-Mitchell, R A Kempf, et al.
Cancer|July 1, 1978
Combination chemotherapy for advanced breast cancer: two regimens containing adriamycinG T Kennealey, B Boston, M S Mitchell, et al.
Pageof 18